ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.7919
0.00%
Brent Oil
80.005
0.00%
Bitcoin
104,346.60
0.21%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Enveric Biosciences Inc (ENVB)

  7. Enveric Biosciences Inc (ENVB) Noticias

ENVB

Enveric Biosciences (ENVB)

Enveric Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ENVB
FechaHoraFuenteTítuloSímboloCompañía
14/01/202516:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
06/01/202516:04Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ENVBEnveric Biosciences Inc
06/01/202508:10Business WireEnveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”NASDAQ:ENVBEnveric Biosciences Inc
18/12/202407:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ENVBEnveric Biosciences Inc
12/12/202411:04Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ENVBEnveric Biosciences Inc
02/12/202407:00Business WireEnveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series CompoundsNASDAQ:ENVBEnveric Biosciences Inc
27/11/202415:36Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ENVBEnveric Biosciences Inc
25/11/202408:00Business WireEnveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like BehaviorNASDAQ:ENVBEnveric Biosciences Inc
22/11/202415:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
14/11/202415:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENVBEnveric Biosciences Inc
14/11/202415:05Business WireEnveric Biosciences Reports Third Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
13/11/202410:18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ENVBEnveric Biosciences Inc
12/11/202408:00Business WireEnveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002NASDAQ:ENVBEnveric Biosciences Inc
04/11/202409:36Business WireEnveric Biosciences Announces Broad Range of Patent IssuancesNASDAQ:ENVBEnveric Biosciences Inc
15/10/202407:00Business WireEnveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003NASDAQ:ENVBEnveric Biosciences Inc
11/10/202418:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
26/09/202407:30Business WireEnveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial WorkshopNASDAQ:ENVBEnveric Biosciences Inc
25/09/202407:30Business WireEnveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug SummitNASDAQ:ENVBEnveric Biosciences Inc
12/09/202408:35Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ENVBEnveric Biosciences Inc
11/09/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENVBEnveric Biosciences Inc
04/09/202407:00Business WireEnveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ENVBEnveric Biosciences Inc
13/08/202407:00Business WireAries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other ConditionsNASDAQ:ENVBEnveric Biosciences Inc
12/08/202416:30Business WireEnveric Biosciences Reports Second Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
25/07/202407:00Business WireEnveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed OrallyNASDAQ:ENVBEnveric Biosciences Inc
15/07/202408:02Business WireAries Science & Technology and Enveric Biosciences Announce Licensing AgreementNASDAQ:ENVBEnveric Biosciences Inc
10/07/202407:00Business WireEnveric Biosciences Announces Patent Granted for Drug CandidateNASDAQ:ENVBEnveric Biosciences Inc
08/07/202416:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
25/06/202407:00Business WireEnveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development CandidateNASDAQ:ENVBEnveric Biosciences Inc
03/06/202417:58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
30/05/202407:00Business WireEnveric Biosciences to Participate in BIO International Convention 2024NASDAQ:ENVBEnveric Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENVB

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
FX
EURUSD
Euro vs US Dollar
COIN
ETHUSD
Ethereum
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
NYSE
VZ
Verizon Communications
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
FX
EURMXN
Euro vs MXN
COIN
ADAUSD
Cardano
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados